Drug Delivery

Aug 26, 2015
The company announced plans to begin PIONEER, a Phase IIIa program comprising seven trials of approximately 8000 people with type 2 diabetes.
Aug 01, 2015
BioPharm International
Gene and cell therapies represent the next-generation treatments for a wide range of diseases, but one challenge in the development of these therapeutics is the controlled delivery to the targeted site to maximize expression or engraftment while limiting systemic exposure.
Aug 01, 2015
BioPharm International
Industry experts spoke to BioPharm International about the key considerations in the development of a drug-delivery device for a biologic drug, the importance of human factors engineering, the advantages of prefilled syringes, and the challenges in the manufacture of these devices.
Jul 23, 2015
By BioPharm International Editors
The Catalent Applied Drug Delivery Institute and AAPS recognize four groups for emerging scientific talent and academic excellence.
Jul 15, 2015
By BioPharm International Editors
Two companies have been fined a total of GBP550,000 for faulty insulin syringes, which contained no drug and caused the death of a diabetic patient.
Jul 15, 2015
By BioPharm International Editors
Mylan issued a voluntary withdrawal of calcium chloride intravenous infusion 10% w/v 10mL prefilled syringe due to difficulties in administration.
Jul 01, 2015
By BioPharm International Editors
The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.
May 28, 2015
By BioPharm International Editors
Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder.
May 11, 2015
By BioPharm International Editors
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
Apr 24, 2015
By BioPharm International Editors
Dicerna Pharmaceuticals announces that FDA granted its primary hyperoxaluria type 1 (PH1) treatment Orphan Drug designation.
native1_300x100
lorem ipsum